Canine tumors: A spontaneous animal model of human carcinogenesis

Translational Research

Volumn 159, Issue 3, 2012, Pages 165-172

  Pinho, Salomé S ^a,b   Carvalho, Sandra ^a   Cabral, Joana ^a   Reis, Celso A ^a,b   Gärtner, Fátima ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

akt murine thymoma viral oncogene homolog 1; AKT1; EGFR; epidermal growth factor receptor; ER; ERA; estrogen receptor; estrogen receptor alpha; indolinone receptor tyrosine kinase; MAPK; mitogen activated protein kinase; phosphatase and tensin homolog; phosphatidylinositol 3 kinase; phosphoinositide 3 kinase, catalytic, alpha polypeptide; PI3K; PIK3CA; PR; progesterone receptor; PTEN; RTK; WHO; World Health Organization

Indexed keywords

BETA CATENIN; BRCA1 PROTEIN; BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR ALPHA; K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; P CADHERIN; PEGYLATED TUMOR NECROSIS FACTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGESTERONE RECEPTOR; PROTEIN KINASE B; PROTEIN P53; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SIALYL LEWIS X ANTIGEN; TOCERANIB; UNCLASSIFIED DRUG; UVOMORULIN;

ANTINEOPLASTIC ACTIVITY; AUTOPHAGY; BREAST CANCER; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; COMPARATIVE STUDY; DNA REPAIR; DOG; DOWN REGULATION; GENE MUTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84857276564     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2011.11.005     Document Type: Review

References (87)

1. I. Gordon, and C. Khanna Modeling opportunities in comparative oncology for drug development ILAR J 51 2010 214 220
2. J.I. Johnson, S. Decker, and D. Zaharevitz Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials Br J Cancer 84 2001 1424 1431 (Pubitemid 32522115)
3. R.A. MacLeod, W.G. Dirks, and Y. Matsuo Widespread intraspecies cross-contamination of human tumor cell lines arising at source Int J Cancer 83 1999 555 563 (Pubitemid 29489873)
4. J.R. Masters HeLa cells 50 years on: the good, the bad and the ugly Nat Rev Cancer 2 2002 315 319 (Pubitemid 37336517)
5. A. Magalhães, J. Gomes, and M.N. Ismail Fut2-null mice display an altered glycosylation profile and impaired BabA-mediated Helicobacter pylori adhesion to gastric mucosa Glycobiology 19 2009 1525 1536
6. A. Richmond, and Y. Su Mouse xenograft models vs GEM models for human cancer therapeutics Dis Model Mech 1 2008 78 82
7. K. Hansen, and C. Khanna Spontaneous and genetically engineered animal models; use in preclinical cancer drug development Eur J Cancer 40 2004 858 880 (Pubitemid 38519765)
8. R. Simon Lost in translation: problems and pitfalls in translating laboratory observations to clinical utility Eur J Cancer 44 2008 2707 2713
9. J.C. Schuh Trials, tribulations, and trends in tumor modeling in mice Toxicol Pathol 32 2004 53 66 (Pubitemid 38437568)
10. N.W. Kim, M.A. Piatyszek, and K.R. Prowse Specific association of human telomerase activity with immortal cells and cancer Science 266 1994 2011 2015
11. K.R. Prowse, and C.W. Greider Developmental and tissue-specific regulation of mouse telomerase and telomere length Proc Natl Acad Sci U S A 92 1995 4818 4822
12. A. Rangarajan, and R.A. Weinberg Opinion: comparative biology of mouse versus human cells: modelling human cancer in mice Nat Rev Cancer 3 2003 952 959 (Pubitemid 37500180)
13. B.A. Teicher In vivo/ex vivo and in situ assays used in cancer research: a brief review Toxicol Pathol 37 2009 114 122
14. E.G. MacEwen Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment Cancer Metastasis Rev 9 1990 125 136 (Pubitemid 20311829)
15. D.M. Vail, and E.G. MacEwen Spontaneously occurring tumors of companion animals as models for human cancer Cancer Invest 18 2000 781 792
16. M.C. Paoloni, and C. Khanna Comparative oncology today Vet Clin North Am Small Anim Pract 37 2007 1023 1032 (Pubitemid 47578468)
17. C. Khanna, K. Lindblad-Toh, and D. Vail The dog as a cancer model Nat Biotechnol 24 2006 1065 1066
18. M. Paoloni, and C. Khanna Translation of new cancer treatments from pet dogs to humans Nat Rev Cancer 8 2008 147 156 (Pubitemid 351161319)
19. E.F. Kirkness, V. Bafna, and A.L. Halpern The dog genome: survey sequencing and comparative analysis Science 301 2003 1898 1903 (Pubitemid 37221394)
20. K. Lindblad-Toh, C.M. Wade, and T.S. Mikkelsen Genome sequence, comparative analysis and haplotype structure of the domestic dog Nature 438 2005 803 819 (Pubitemid 41753059)
21. P. Uva, L. Aurisicchio, and J. Watters Comparative expression pathway analysis of human and canine mammary tumors BMC Genomics 10 2009 135
22. L.H. Saal, P. Johansson, and K. Holm Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity Proc Natl Acad Sci U S A 104 2007 7564 7569 (Pubitemid 47185946)
23. A. Galanis, A. Pappa, and A. Giannakakis Reactive oxygen species and HIF-1 signalling in cancer Cancer Lett 266 2008 12 20
24. C.A. Castaneda, H. Cortes-Funes, H.L. Gomez, and E.M. Ciruelos The phosphatidyl inositol 3- kinase/AKT signaling pathway in breast cancer Cancer Metastasis Rev 29 2010 751 759
25. R.L. Dillon, D.E. White, and W.J. Muller The phosphatidyl inositol 3- kinase signaling network: implications for human breast cancer Oncogene 26 2007 1338 1345 (Pubitemid 46328463)
26. A. Sweet-Cordero, S. Mukherjee, and A. Subramanian An oncogenic KRAS2 expression signature identified by cross-species gene- expression analysis Nat Genet 37 2005 48 55 (Pubitemid 40070939)
27. L. Ressel, F. Millanta, E. Caleri, V.M. Innocenti, and A. Poli Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors Vet Pathol 46 2009 860 868
28. K.M. Cadigan, and R. Nusse Wnt signaling: a common theme in animal development Genes Dev 11 1997 3286 3305 (Pubitemid 28023954)
29. A. Klaus, and W. Birchmeier Wnt signalling and its impact on development and cancer Nat Rev Cancer 8 2008 387 398 (Pubitemid 351589714)
30. H. Suzuki, M. Toyota, and H. Carraway Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer Br J Cancer 98 2008 1147 1156 (Pubitemid 351399804)
31. N.A. Rao, M.E. van Wolferen, and R. van den Ham cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype Animal Genet 39 2008 333 345 (Pubitemid 351989267)
32. J.S. Sebolt-Leopold, and R. Herrera Targeting the mitogen-activated protein kinase cascade to treat cancer Nat Rev Cancer 4 2004 937 947 (Pubitemid 39626217)
33. J. Chang, and R.M. Elledge Clinical management of women with genomic BRCA1 and BRCA2 mutations Breast Cancer Res Treat 69 2001 101 113 (Pubitemid 33079017)
34. I. Biche, C. Nogus, and R. Lidereau Overexpression of BRCA2 gene in sporadic breast tumours Oncogene 18 1999 5232 5238 (Pubitemid 29460659)
35. H. Maacke, S. Opitz, and K. Jost Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer Int J Cancer 88 2000 907 913
36. M.E. Thompson, R.A. Jensen, P.S. Obermiller, D.L. Page, and J.T. Holt Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression Nat Genet 9 1995 444 450
37. R. Klopfleisch, and A.D. Gruber Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary Aden carcinomas Vet Pathol 46 2009 416 422
38. A. Nieto, M.D. Pérez-Alenza, and N. Del Castillo BRCA1 expression in canine mammary dysplasias and tumours: relationship with prognostic variables J Comp Pathol 128 2003 260 268 (Pubitemid 36531661)
39. D.J. Jerry, K.A. Dunphy, and M.J. Hagen Estrogens, regulation of p53 and breast cancer risk: a balancing act Cell Mol Life Sci 67 2010 1017 1023
40. R. Klopfleisch, and A.D. Gruber Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands Res Vet Sci 87 2009 91 96
41. C.H. Lee, W.H. Kim, and J.H. Lim Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors J Vet Sci 5 2004 63 69
42. A. Setoguchi, T. Sakai, and M. Okuda Aberrations of the p53 tumor suppressor gene in various tumors in dogs Am J Vet Res 62 2001 433 439 (Pubitemid 33605602)
43. E.A. Ariazi, J.L. Ariazi, F. Cordera, and V.C. Jordan Estrogen receptors as therapeutic targets in breast cancer Curr Top Med Chem 6 2006 181 202
44. F. Cordera, and V.C. Jordan Steroid receptors and their role in the biology and control of breast cancer growth Semin Oncol 33 2006 631 641 (Pubitemid 44834535)
45. S.J. Howell, S.R. Johnston, and A. Howell The use of selective estrogen receptor modulators and selective estrogen receptor down regulators in breast cancer Best Pract Res Clin Endocrinol Metab 18 2004 47 66 (Pubitemid 38324626)
46. J.M. de Las Mulas, Y. Millán, and R. Dios A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog Vet Pathol 42 2005 200 212 (Pubitemid 40797309)
47. M. Geraldes, F. Gärtner, and F. Schmitt Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumors Vet Rec 146 2000 403 406
48. A. Nieto, L. Peña, and M.D. Pérez-Alenza Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance Vet Pathol 37 2000 239 247
49. S.S. Pinho, C.A. Reis, F. Gärtner, and M.L. Alpaugh Molecular plasticity of E-cadherin and sialyl lewis x expression, in two comparative models of mammary tumorigenesis PLoS One 4 2009 e6636
50. S. Baranwal, and S.K. Alahari Molecular mechanisms controlling E-cadherin expression in breast cancer Biochem Biophys Res Commun 384 2009 6 11
51. S.C. Chang, C.C. Chang, T.J. Chang, and M.L. Wong Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002) J Am Vet Med Assoc 227 2005 1625 1629
52. E. Hellmén, R. Bergström, and L. Holmberg Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases Vet Pathol 30 1993 20 27
53. A.J. De Matos, C.C. Lopes, and A.M. Faustino E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours APMIS 115 2007 327 334 (Pubitemid 46745228)
54. A. Gama, J. Paredes, F. Gärtner, A. Alves, and F. Schmitt Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival Vet J 117 2008 45 53 (Pubitemid 351753675)
55. A.J. Matos, C. Lopes, and J. Carvalheira E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables J Comp Pathol 134 2006 182 189
56. J. Paredes, A.L. Correia, and A.S. Ribeiro P-cadherin expression in breast cancer: a review Breast Cancer Res 9 2007 214
57. J. Paredes, A. Albergaria, and J.T. Oliveira P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation Clin Cancer Res 11 2005 5869 5877 (Pubitemid 41170315)
58. A. Gama, J. Paredes, A. Albergaria, F. Gartner, and F. Schmitt P-cadherin expression in canine mammary tissues J Comp Pathol 130 2004 13 20 (Pubitemid 38185948)
59. M.L. Burness, T.A. Grushko, and O.I. Olopade Epidermal growth factor receptor in triple-negative and basal-like breast cancer: promising clinical target or only a marker? Cancer J 16 2010 23 32
60. J. Foley, N.K. Nickerson, and S. Nam EGFR signaling in breast cancer: bad to the bone Semin Cell Dev Biol 21 2010 951 960
61. A. Gama, F. Gärtner, A. Alves, and F. Schmitt Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues Res Vet Sci 87 2009 432 437
62. G.R. Rutteman, J.A. Foekens, and H. Portengen Expression of epidermal growth factor receptor (EGFR) in non-affected and tumorous mammary tissue of female dogs Breast Cancer Res Treat 30 1994 139 146 (Pubitemid 24242665)
63. K. Sorenmo Canine mammary gland tumors Vet Clin North Am Small Anim Pract 33 2003 573 596 (Pubitemid 36798638)
64. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66 (Pubitemid 46148091)
65. L.N. Owen A comparative study of canine and human breast cancer Invest Cell Pathol 2 1979 257 275 (Pubitemid 10172451)
66. W. Misdorp, R.W. Else, E. Hellmén, and T.P. Lipscomb Histological classification of mammary tumors of the dog and the cat 1999 Armed Forces Institute of Pathology Washington, DC
67. C. Khanna, and HK Modeling metastasis in vivo Carcinogenesis 26 2005 513 523 (Pubitemid 41214139)
68. A.R. Venkitaraman Cancer susceptibility and the functions of BRCA1 and BRCA2 Cell 108 2002 171 182 (Pubitemid 34161138)
69. J.F. Millau, N. Bastien, and R. Drouin P53 transcriptional activities: a general overview and some thoughts Mutat Res 681 2009 118 133
70. P.N. Olson Using the canine genome to cure cancer and other diseases Theriogenology 68 2007 378 381 (Pubitemid 47017432)
71. C.C. Chang, M.H. Tsai, and J.W. Liao Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors J Am Vet Med Assoc 235 2009 391 396
72. G. Shyamala, Y.C. Chou, and S.G. Louie Cellular expression of estrogen and progesterone receptors in mammary glands: regulation by hormones, development and aging J Steroid Biochem Mol Biol 80 2002 137 148 (Pubitemid 34233736)
73. S.S. Pinho, A.J. Matos, and C. Lopes Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression BMC Cancer 7 2007 124
74. J.T. de Oliveira, A.J. de Matos, and J. Gomes Coordinated expression of galectin-3 and galectin-3-binding sites in malignant mammary tumors: implications for tumor metastasis Glycobiology 20 2010 1341 1352
75. S.S. Pinho, H. Osório, and M. Nita-Lazar Role of E-cadherin N-glycosylation profile in a mammary tumor model Biochem Biophys Res Commun 379 2009 1091 1096
76. J.L. Rowell, D.O. McCarthy, and C.E. Alvarez Dog models of naturally occurring cancer Trends Mol Med 17 2011 380 388
77. C. Khanna, C. London, D. Vail, C. Mazcko, and S. Hirschfeld Guiding the optimal translation of new cancer treatments from canine to human cancer patients Clin Cancer Res 15 2009 5671 5677
78. M. Paoloni, and C. Khanna Translation of new cancer treatments from pet dogs to humans Nat Rev Cancer 8 2008 147 156 (Pubitemid 351161319)
79. G.S. Mack Clinical trials going to the dogs: canine program to study tumor treatment, biology J Natl Cancer Inst 98 2006 161 162
80. D.H. Thamm, I.D. Kurzman, and M.A. Clark Preclinical investigation of PEGylated tumor necrosis factor alpha in dogs with spontaneous tumors: phase I evaluation Clin Cancer Res 16 2010 1498 1508
81. C.A. London, A.L. Hannah, and R. Zadovoskaya Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies Clin Cancer Res 9 2003 2755 2768 (Pubitemid 36842122)
82. A. Ullrich, and J. Schlessinger Signal transduction by receptors with tyrosine kinase activity Cell 61 1990 203 212
83. J. Griffin The biology of signal transduction inhibition: basic science to novel therapies Semin Oncol 28 2001 3 8 (Pubitemid 33140512)
84. G. De Vico, P. Maiolino, B. Restucci, and A. Passantino Spontaneous tumours of pet dog as models for human cancers: searching for adequate guidelines Riv Biol 98 2005 279 296 (Pubitemid 41412246)
85. K.A. Hahn, L. Bravo, W.H. Adams, and D.L. Frazier Naturally occurring tumors in dogs as comparative models for cancer therapy research In Vivo 8 1994 133 143 (Pubitemid 24156544)
86. A. Porrello, P. Cardelli, and E.P. Spugnini Oncology of companion animals as a model for humans. an overview of tumor histotypes J Exp Clin Cancer Res 25 2006 97 105
87. I. Gordon, M. Paoloni, C. Mazcko, and C. Khanna The Comparative Oncology Trials Consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway PLoS Med 6 2009 e1000161